Digital Twins Risks, Limitations, And Regulatory Landscape
Source: Bioprocess Online
In this segment of the Bioprocess Online Live event Biomanufacturing Precision With Digital Twins & Mechanistic Models, we present the results of the second audience poll on what's holding back deployment. The discussion then turns to Pfizer Principal Scientist Hooman Farsani, Ph.D., Takeda Associate Director of Data Analytics & Modeling, Shruti Gopal Vij, Ph.D., Sanofi MSAT Process Engineer, Yuanyuan Cui, Ph.D., and Sanofi Global Head of Process Data Management, ML and AI Platform, MSAT, Ramila Peiris, Ph.D. addressing the risks and limitations of using digital twins in GMP and process development.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more